Exploring the Association between Health-Related Physical Fitness and Quality of Life in Patients with Cancer: A Cross-Sectional Study.

body fat cancer cardiorespiratory fitness physical fitness quality of life strength

Journal

Healthcare (Basel, Switzerland)
ISSN: 2227-9032
Titre abrégé: Healthcare (Basel)
Pays: Switzerland
ID NLM: 101666525

Informations de publication

Date de publication:
17 Aug 2024
Historique:
received: 22 07 2024
revised: 13 08 2024
accepted: 15 08 2024
medline: 31 8 2024
pubmed: 31 8 2024
entrez: 29 8 2024
Statut: epublish

Résumé

Whereas an exercise intervention effectively improves patients' quality of life, little information is available about the contribution of each physical fitness component. This study aims to explore the association between physical fitness components and the quality-of-life domain in patients with cancer. Between September 2021 and August 2023, 160 patients with mixed cancer types visiting the Oncology Unit were selected on a consecutive basis according to selection criteria. They underwent a comprehensive baseline assessment including the six-minute walking test, the handgrip strength test, the isometric leg press test, the back scratch, sit and reach tests, their waist-hip ratio, and their body mass index. The European Organization for Research and Treatment of Cancer Quality of Life and Core Questionnaire was used to measure the quality of life. The sample size was based on the use of regression models to study associations between clinical characteristics and fitness outcomes. All of the analyses were performed using the SPSS v.25 statistical package. Patients had a mean age of 58 years, 68% were female, 42% were affected by breast cancer, and all were receiving anticancer treatments. Higher functional capacity was associated with better global health status (

Identifiants

pubmed: 39201201
pii: healthcare12161643
doi: 10.3390/healthcare12161643
pii:
doi:

Types de publication

Journal Article

Langues

eng

Auteurs

Anita Borsati (A)

Department of Medicine, University of Verona, 37129 Verona, Italy.

Diana Giannarelli (D)

A. Gemelli University Hospital Foundation, IRCCS-Epidemiology&Biostatistic, 00168 Rome, Italy.

Lorenzo Belluomini (L)

Section of Innovation Biomedicine-Oncology Area, Department of Engineering for Innovation Medicine (DIMI), University of Verona and University and Hospital Trust (AOUI) of Verona, 37126 Verona, Italy.

Christian Ciurnelli (C)

Department of Neuroscience, Biomedicine, and Movement Sciences, University of Verona, 37129 Verona, Italy.

Alessio Colonna (A)

Department of Neuroscience, Biomedicine, and Movement Sciences, University of Verona, 37129 Verona, Italy.

Irene D'Amico (I)

Department of Neuroscience, Biomedicine, and Movement Sciences, University of Verona, 37129 Verona, Italy.

Arianna Daniele (A)

Department of Neuroscience, Biomedicine, and Movement Sciences, University of Verona, 37129 Verona, Italy.

Nicole Del Bianco (N)

Department of Neuroscience, Biomedicine, and Movement Sciences, University of Verona, 37129 Verona, Italy.

Linda Toniolo (L)

Department of Neuroscience, Biomedicine, and Movement Sciences, University of Verona, 37129 Verona, Italy.

Ilaria Trestini (I)

Dietetics Service, Medical Direction, University Hospital of Verona, 37126 Verona, Italy.

Daniela Tregnago (D)

Section of Innovation Biomedicine-Oncology Area, Department of Engineering for Innovation Medicine (DIMI), University of Verona and University and Hospital Trust (AOUI) of Verona, 37126 Verona, Italy.

Jessica Insolda (J)

Section of Innovation Biomedicine-Oncology Area, Department of Engineering for Innovation Medicine (DIMI), University of Verona and University and Hospital Trust (AOUI) of Verona, 37126 Verona, Italy.

Marco Sposito (M)

Section of Innovation Biomedicine-Oncology Area, Department of Engineering for Innovation Medicine (DIMI), University of Verona and University and Hospital Trust (AOUI) of Verona, 37126 Verona, Italy.

Massimo Lanza (M)

Department of Neuroscience, Biomedicine, and Movement Sciences, University of Verona, 37129 Verona, Italy.

Michele Milella (M)

Section of Innovation Biomedicine-Oncology Area, Department of Engineering for Innovation Medicine (DIMI), University of Verona and University and Hospital Trust (AOUI) of Verona, 37126 Verona, Italy.

Federico Schena (F)

Department of Neuroscience, Biomedicine, and Movement Sciences, University of Verona, 37129 Verona, Italy.

Sara Pilotto (S)

Section of Innovation Biomedicine-Oncology Area, Department of Engineering for Innovation Medicine (DIMI), University of Verona and University and Hospital Trust (AOUI) of Verona, 37126 Verona, Italy.

Alice Avancini (A)

Section of Innovation Biomedicine-Oncology Area, Department of Engineering for Innovation Medicine (DIMI), University of Verona and University and Hospital Trust (AOUI) of Verona, 37126 Verona, Italy.
Department of Neuroscience, Biomedicine, and Movement Sciences, University of Verona, 37129 Verona, Italy.

Classifications MeSH